Filtered By:
Nutrition: Organic
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 75442 results found since Jan 2013.
Owlstone Medical raises $15m to commercialize breath biopsy platform
Owlstone Medical touted today that it raised $15 million to support the commercialization of its breathalyzer diagnostic device.
Funds from the round, co-led by Horizons Ventures and Aviva Ventures, will also be used to expand the company’s pipeline and the precision medicine services that it provides to the pharma industry, according to the Cambridge, England-based company.
Owlstone Medical’s breath biopsy platform is designed to measure volatile organic compounds in a person’s breath as a means to diagnose particular diseases.
The company has collaborated with Cancer Research U.K. to launch a study eval...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Funding Roundup Oncology Owlstone Medical Source Type: news
Globus Medical Q3 beats The Street
Globus Medical (NYSE:GMED) today posted third quarter earnings that handily topped expectations from analysts on Wall Street.
The Audubon, Pa.-based company posted profits of $35.2 million, or 35¢ per share, on sales of $169.2 million for the three months ended September 30, for bottom-line growth of 37.6% on sales growth of 11.5% compared with the same period last year.
Adjusted to exclude one-time items, earnings per share were 39¢, ahead of the 32¢ consensus on The Street, where analysts were looking for sales of $167.5 million, which the company topped.
“The third quarter marks the fourth consecutive quarter ...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat Globus Medical Source Type: news
Cantel Medical slumps on fiscal Q2 misses
Cantel Medical (NYSE:CMD) shares took a hit this week when the medical device company missed the consensus forecast with its fiscal second-quarter results.
Little Falls, N.J.-based Cantel posted a -42.1% profit slide to $18.8 million, or 45¢ per share, on sales of $224.5 million for the three months ended Jan. 31, for top-line growth of 5.4% compared with fiscal Q2 2018.
Adjusted to exclude one-time items, earnings per share were 57¢, a nickel below the consensus on Wall Street, where analysts were looking for revenues of $226.9 million.
“We are pleased to see continued strong double-digit sales growth in our medi...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Cantel Medical Corp. Source Type: news
Cantel Medical taps ex-Cardinal Health COO Fotiades for CEO | Personnel Moves, March 5, 2019
Cantel Medical taps ex-Cardinal Health vet for CEO
Cantel Medical (NYSE:CMD) said today that it named former Cardinal Health (NYSE:CAH) COO George Fotiades to be its new president & CEO, replacing Jorgen Hansen effective immediately. Fotiades will retain his seat on Cantel’s board, the Little Falls, N.J.-based company said.
“On behalf of the board, I am very pleased to appoint George as Cantel’s new president & CEO. His experience leading companies through significant growth, creating organizational capabilities on a global scale and integrating acquired businesses make him the ideal candidate...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Blog Activ Surgical BioDirection Cantel Medical Corp. cathworks CHF Solutions Inc. Globus Medical Misonix Personnel Moves sciton Sensus Healthcare LLC Zynex Source Type: news
Natus Medical Q1 results beat The Street despite swing to red ink
Shares in Natus Medical (Nasdaq: BABY) fell today after the newborn-focused medical device maker posted first quarter earnings that saw profits turn to losses, despite topping Wall Street expectations for sales and earnings per share.
The Pleasanton, Calif.-based company posted losses of approximately $3.2 million, or 10¢ per share, on sales of $128.6 million for the three months ended March 31, seeing a massive swing from profits on the bottom-line while sales grew 3.2% compared with the same period during the previous year.
After adjusting for one-time items, earnings per share were 24¢, just in line with the 24¢ co...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Natus Medical Inc. Source Type: news
Natus Medical beats Q2 estimates, cuts full-year guidance
Shares in Natus Medical (NSDQ:BABY) rose today after the company topped expectations on Wall Street with its second-quarter financial results.
The Pleasanton, Calif.-based company posted a net loss of -$2.6 million, or -8¢ per share, on sales of $130.7 million for the 3 months ended June 30, for sales growth of 7% compared with the same period last year.
Adjusted to exclude 1-time items, earnings per share were 35¢, ahead of consensus on The Street, where analysts were looking for sales of $130.5 million.
“Our non-GAAP earnings per share considerably exceeded our guidance at 35 cents. Our improved margins reflect ...
Source: Mass Device - July 25, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News MassDevice Earnings Roundup Pediatrics Wall Street Beat Natus Medical Inc. Source Type: news
Globus Medical whales on Wall Street ’ s Q2 expectations
Globus Medical (NYSE:GMED) today whaled on the consensus expecation with its second-quarter results and raised its outlook for the rest of the year.
Audubon, Pa.-based Globus posted profits of $45.0 million, or 44¢ per share, on sales of $173.4 million for the three months ended June 30, for a bottom-line gain of 56.9% on sales growth of 13.8% compared with Q2 2017.
Adjusted to exclude one-time items, earnings per share were 44¢, 9¢ ahead of The Street, where analysts were looking for sales of $168.0 million.
“The second quarter marks the third consecutive quarter of double-digit organic growth for Globus Medical...
Source: Mass Device - August 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Orthopedics Wall Street Beat Globus Medical personnel-moves Source Type: news
BTG invests $20m in Veran Medical ’ s thoracic guidance tech
BTG (LON:BTG) said this week that it invested $20 million in Veran Medical Technologies and its thoracic navigation system.
Veran’s thoracic navigation system is designed to help lung specialists diagnose lung cancer earlier, enabling a smooth transition between an endobronchial and transthoracic approach. The technology is also used to localize and mark lung nodules in the operating room prior to resection.
The London-based company has an option to acquire Veran, exercisable from January 2020.
“We are excited to announce BTG’s investment in Veran and look forward to collaborating with them,” Veran Medi...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured MassDevice Earnings Roundup Oncology Wall Street Beat BTG Veran Medical Technologies Source Type: news
Cantel Medical ’ s fiscal Q1 earnings meet The Street, but sales miss
Fiscal first-quarter earnings for Cantel Medical (NYSE:CMD) equaled the consensus forecast on Wall Street, but the medical device company miss the mark with its top-line number.
Little Falls, N.J.-based Cantel posted profits of $19.2 million, or 46¢ per share, on sales of $225.6 million for the three months ended Oct. 31, for a bottom-line slide of -16.1% on sales growth of 6.0% compared with fiscal Q1 2018.
Adjusted to exclude one-time items, earnings per share were 62¢ per share, dead even with The Street, where analysts were looking for revenues of $228.2 million.
“We are pleased to report good sales and non-GA...
Source: Mass Device - November 29, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured MassDevice Earnings Roundup Wall Street Beat Cantel Medical Corp. Source Type: news
Cantel Medical ’ s fiscal Q2 beats expectations
Cantel Medical (NYSE:CMD) beat the consensus forecast with its fiscal second-quarter results today, but received a tepid reaction on Wall Street.
Little Falls, N.J.-based Cantel posted profits of $32.5 million, or 78¢ per share, on sales of $213.0 million for the three months ended Jan. 31, for a bottom-line gain of 79.8% on sales growth of 15.3% compared with the same period in fiscal 2017.
Adjusted to exclude one-time items, earnings per share were 71¢, 14¢ ahead of the consensus on The Street, where analysts were looking for sales of $211.4 million.
“We are pleased to report record sales and earnings performan...
Source: Mass Device - March 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Cantel Medical Corp. Source Type: news
Wright Medical Defends Clinical Performance of Cartiva Implant
Wright Medical reported weaker-than-expected sales of its recently-acquired Cartiva implant in the second-quarter, prompting the company to reduce its guidance for the year. The news comes amid some investor concerns and analyst commentary regarding the clinical performance and market opportunity for Cartiva.
Wright shelled out $435 million to acquire Cartiva last year. FDA approved the Cartiva Synthetic Cartilage Implant (SCI) for treating arthritis at the base of the great toe in July 2016. The implant is composed of a biocompatible, durable, low-friction organic polymer designed to function simil...
Source: MDDI - August 8, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Business Source Type: news
Physician Palliative Education Associated With High Use of Hospice Care Service
CONCLUSIONS: Physicians' palliative education was found to be an independent factor associated with higher use of hospice care. The findings suggest increasing palliative and hospice education among physicians so that they can ensure that their patients have high-quality end-of-life medical care in an aging society.PMID:33960206 | DOI:10.1177/10499091211014160
Source: The American Journal of Hospice and Palliative Care - May 7, 2021 Category: Palliative Care Authors: Mei-Hsing Chuang Fang-Niarn Lee Yih-Tsong Shiau Hsiu-Yi Shen Chih-Ching Lee Saint Shiou-Sheng Chen Sheng-Jean Huang Source Type: research
